Magnetoencephalography (MEG) is a non-invasive method for studying magnetic fields generated by simultaneously firing neurons outside the skull. The skull, scalp and brain tissue do not distort magnetic fields, so the cortical activity can be easily measured. MEG is starting to be used to explore the effects of various psychopharmacological agents on resting brain, sensory and cognitive processing. Scopolamine and agents enhancing GABA functions have shown differential effects on cortical neural oscillations. Further, with GABA, serotonin, dopamine and acetylcholine transmissions have differential effects on early cortical and pre-attentional processing in the auditory and frontal cortices. Monoamines also differently regulate the activity of the somatosensory cortex. Taken together, MEG with a resolution of milliseconds allows exploration of focal cortical effects of psychopharmacological agents giving information different from other brain-imaging modalities.
Introduction
Neuropsychological methods have significantly contributed to an understanding of the actions of psychopharmacological drugs in the human central nervous system (CNS). However, the brain mechanisms responsible for these effects can be revealed only by studying the brain itself. Several functional imaging techniques such as positron emission tomography, single photon emission computed tomography and functional magnetic resonance imaging have enabled the location of changes in drug occupancy, metabolism and blood flow induced by CNS drugs (Chen et al., 2001 ; Talbot and Laruelle, 2002) . However, changes in metabolism or blood flow are indirect reflections of neural activation. Direct information about neural activation can be studied using the electroencephalography (EEG) enabling the detection of CNS drug-related changes in activation with millisecond resolution. However, due to skull conductivity in EEG, the separation of sources underlying the activations is limited. Recently, magnetoencephalography (MEG) has been used to investigate the effects of drugs on different brain functions. With MEG the effects of different drugs on the cortex can be studied with high spatial accuracy in a few millimetres and with equal temporal resolution as with EEG.
Principles of MEG
When a neuron is active, small currents flow in the intra-and extracellular space. Synchronous activation of many neurons can be measured as the difference of potentials between two points on the scalp with EEG. Nerve cells also generate intracellular current flow from dendrites to the cell body, resulting in a magnetic field that can be detected on the scalp as with SQUID (superconducting quantum interference device) sensors (Figure 1 ). The unique feature of the MEG technique is the relative transparency of the skull, scalp and brain tissue to the magnetic fields. An EEG signal, on the other hand, is strongly influenced by the head properties. MEG mainly detects the tangential cortical sources (Hämäläinen et al., 1993) , and, therefore, measures the electromagnetic activity from the cortical fissures. EEG in turn detects both tangential sources and particularly the radial currents generated by the cortical gyri. In addition, MEG is reference-free, whereas EEG is dependent on the location of the reference site. During recent years the instrumentation of MEG devices has been developed and over 300-channel whole-head devices have been built. These new devices can be used to compute the distribution of cerebral activity accurately as a function of time. MEG's unique combination of characteristics include its non-invasiveness, simple and quick procedures, good accuracy in locating sources, and excellent time resolution in milliseconds. In this overview, the effects of CNS drugs in single doses using placebo control on cortical functions in healthy subjects investigated with MEG are reviewed.
Effects of psychopharmacological agents on cortical oscillations
MEG can be used for studying the cortical rhythmic activation (oscillation) reflecting the state of the resting and activated brain (Hari and Salmelin, 1997) . Typically, the power spectrum (signal strength) is divided into frequency bands, including delta (<4 Hz), theta (4-8 Hz), alpha (8-13 Hz), beta (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . Although EEG has been used to study the effects of psychopharmacological agents on cortical oscillations for decades (for a review see Saletu et al., 2002) , MEG has been utilized for these purposes only recently. Osipova et al. (2003) studied the effects of scopolamine, an anti-muscarinic agent compared to glucopyrrolate (a peripheral anti-muscarinic drug), in a controlled, cross-over study design in elderly subjects on power spectrum and coherence with whole-head MEG. Scopolamine administration increased theta activity and resulted in the abnormal pattern of alpha-band activation in eyes-open vs. eyesclosed conditions. Significant scopolamine-induced reduction of inter-hemispheric and left hemisphere coherence (calculated as cross-correlation by power spectra between the channels) was observed in the theta band. These effects were most prominent over central and temporal cortical regions. Results of scopolamine challenge suggest that parietal and temporal cortices may also mediate some symptoms of Alzheimer's disease, as acetylcholine-mediated changes have been observed in this neurodegenerative disorder (Geula and Mesulam, 1994) . In another crossover study, alcohol decreased beta-activity and increased alpha-activity in occipital regions similarly in both hemispheres compared with placebo studied with whole-head MEG and EEG. The effects were visible in MEG, but not in EEG (Nikulin et al., 2005) . This study indicates that MEG can reveal different aspects of drug-induced changes on cortical oscillations than EEG. Another GABA agonist lorazepam had the opposite effect on brain oscillations : betaactivity increased and alpha-activity decreased, the effects being similar in MEG and EEG (Fingelkurts et al., 2004) . To summarize, these studies show that MEG is well suited for studying local cortical effects of different CNS drugs on the resting brain and can separate the effects of different drugs on oscillations.
Event-related magnetic fields for studying sensory processing
Event-related magnetic fields (ERFs) are time-locked MEG changes to sensory (auditory, somatosensory, and visual), motor, or cognitive events, providing a neurophysiological reflection of the processing of these events in millisecond resolution. ERFs result from intracellular currents induced by excitatory and inhibitory post-synaptic potentials, which are triggered by the release of various neurotransmitters, allowing the underlying neurochemical mechanisms to be studied by psychopharmacological challenges (Frodl-Bauch et al., 1999) .
Drug effects on early auditory processing
The earliest cortical responses, middle-latency auditory-evoked fields (MAEF), are generated 10-50 ms from click presentation to the ear. MAEFs are composed of several distinct deflections, with the most invariable components N a m and P a m peaking at y25 ms and y40 ms post-stimulus respectively. Their generators lie near the primary auditory cortices (Mäkelä et al., 1994) . Acute tryptophan depletion (ATD) leading to decreased serotonin synthesis in the brain has been shown to modulate N a m and P a m amplitudes and latencies (Kähkö nen et al., 2002) . When ATD has been used in studies as an experimental model for depression (Moore et al., 2000) , changes in MAEFs suggest that patients with major depression may have deficits in early auditory processing. By contrast, the dopamine D 2 -receptor antagonist haloperidol did not have any effects on MAEFs (Kähkö nen et al., 2001). Further, scopolamine, an antimuscarinic agent decreased P a m source activity in the auditory cortex (Jääskeläinen et al., 1999) . Taken together, these studies on neurochemical modulation of MAEFs suggest that monoamines have differential time-dependent effects in the regulation of early auditory processing in the auditory cortex.
Drug effects on auditory N1m
On average, N1m peaks at 100 ms from stimulus onset. Its main source lies near the supratemporal auditory cortices (Hari et al., 1980 ; Näätänen and Picton, 1987) . The functional significance of N1m has been linked to sound detection (Parasuraman and Beatty, 1980) , formation of auditory memory traces (Näätänen and Picton, 1987) , and also involuntary attention shifting to sudden onsets and offsets of auditory stimuli (Näätänen, 1990) . ATD decreased the intensity dependence of N1m source activity in the auditory cortex (Kähkö nen et al., 2002b) . These results contradict those obtained with EEG (for a review see Hegerl et al., 2002) , indicating that a pronounced intensity dependence of N1 amplitude in the primary auditory cortex reflects low serotonin transmission deficiency. Haloperidol administration decreased N1m latencies (Pekkonen et al., 2002) while scopolamine injection delayed N1m latency ) and alcohol decreased N1m amplitudes (Kähkö nen et al., 2005b) . These studies indicate that sound detection in the auditory cortex is differently affected by dopamine, serotonin, acetylcholine and GABA neurotransmission.
Neural correlates of cognitive processing studied by MEG and EEG Mismatch negativity (MMN) and its magnetic counterpart (MMNm) are auditory-evoked responses, which are time-locked to changes in the EEG or MEG to auditory stimuli. MMN and MMNm, peaking at about 150-200 ms after stimulus onset, are elicited when infrequent deviant sounds are embedded among frequent standard tones. MMN is believed to have several overlapping subcomponents that reflect different phases of detection and orientation to novel stimulus features (Näätänen, 1992) . The detection of a sound change during the processing of deviant stimuli is proposed to elicit a temporal MMN subcomponent, which can be detected accurately by MEG, because it has a tangentially located source in the auditory cortex (Näätänen, 1992) . The subsequent initiation of an involuntary attention shift to this sound change is probably reflected by a later frontal MMN subcomponent (Näätänen, 1992 ; Rinne et al., 2000) . The frontal subcomponent might be radially oriented, judging from the fact that MEG does not detect it (Rinne et al., 2000) . Due to the different orientation of sources involved in the attentional processing of auditory stimuli, the combination of MEG with EEG makes it possible to differentiate neural events related to involuntary attention.
Drug effects on MMNm
MMN is elicited in a passive odd-ball paradigm while the subject is instructed to ignore the sounds. Studies on pre-attentive auditory change detection have indicated that ATD increases MMN amplitudes to frequency and duration changes, and decreases MMNm latencies to duration changes, suggesting that temporal and frontal cortices are involved in serotonin modulation (Kähkö nen et al., 2005a) . Further studies are needed to clarify whether serotonin-related disorders such as major depression and anxiety also have deficits in pre-attentive processing. Haloperidol had a similar effect on MMNm latencies to frequency changes whereas no effects on amplitudes or latencies to duration changes were observed (Pekkonen et al., 2002) . Scopolamine reduced MMNm amplitudes in response to frequency, but not to duration changes . These results are in line with those studies (Pekkonen, 2000) which suggest that memory impairment in Alzheimer's disease is mediated by acetylcholine mechanisms through muscarinic receptors. Lorazepam decreased MMNm source activity to frequency, duration and intensity changes (Rosburg et al., 2004) . The role of GABA on MMN modulation was confirmed by the study in which alcohol reduced MMNm amplitudes (Kähkö nen et al., 2005b) . No placebo-controlled MEG studies about the effects of the glutamate system on MMNm have yet been conducted, but one study in a test-retest design suggests that a subanaesthetic dose of ketamine reduces MMNm source activity (KreitschmannAndermahr et al., 2001 ). These studies indicate that MMN is differently regulated by neurotransmitters in the auditory cortex, depending on the type of deviance.
Effects of monoamine drugs on somatosensory processing
After electrical median nerve stimulation, usually four deflections (N20m, P35m, N45m and P60m) can be distinguished. The strongest and earliest cortical activation after peripheral sensory stimulation is observed in the contralateral primary somatosensory cortex (Wood et al., 1985) . Later, the ipsilateral and contralateral secondary somatosensory cortex, the posterior parietal cortex and the frontal cortex may also be activated (Forss et al., 1994 ; Mauguiere et al., 1997 ; Mima et al., 1997) . Scopolamine reduced P35m and P60m deflections ) and haloperidol decreased the dipole strength of P60m response, but ADT had no effects on somatosensory processing Kähkö nen et al., 2003) . These studies indicate that monoamines modulate somatosensory processing differently.
Conclusions
MEG is a promising brain research tool in psychopharmacology allowing the investigation of the effects of different drugs on the resting and activated brain with high spatial accuracy and temporal resolution. Drug challenges with different agonists and antagonists are able to reveal important aspects of the pathophysiology of neuropsychiatric disorders such as Alzheimer's disease, major depression and drug abuse. MEG directly measures drug-induced changes in neuronal activation giving information which is different from other brain-imaging modalities. As other brain-imaging methods such as fMRI have even better spatial resolution than MEG, a combination of these methods will give more exact temporal and spatial information about drug effects on brain function. Further, in the studies reviewed only one drug dose is used. In future, multiple doses with drug pharmacokinetics are necessary for testing the clinical usefulness of MEG.
